Business Daily Media

Men's Weekly

.

Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio

  • Written by Newsfile
  • patent applications filed for manufacturing processes
  • patent-pending technology aims to improve yields and ultimately margins

Calgary, Alberta--(Newsfile Corp. - October 6, 2021) - Psygen Industries Ltd. ("Psygen" or the "Company") provided an update today on use of psilocybin in humans and on its intellectual property portfolio. Psygen is excited...